Alok Chandra Bharti

Citado por

	Total	Desde 2019
Citas	12607	3893
Índice h	48	31
Índice i10	87	70

800

400

200

600

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202461 232 341 410 396 473 403 467 632 671 717 724 767 756 723 774 717 748 783 752 643 250

Acceso público

Ver todo

35 artículos

14 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Ravi MehrotraFred Hutchinson Cancer Center/Univ. of WashingtonDirección de correo verificada de gov.in
Dr. Showket HussainDivision of Molecular Diagnostics & Mol. Oncology ICMR- National Institute of Cancer PreventionDirección de correo verificada de gov.in
Seemi Farhat BasirJamia Millia IslamiaDirección de correo verificada de jmi.ac.in
Ajay K Chaudhary PhDSr. Application Scientist-South Asia (SA), BGI GenomicsDirección de correo verificada de roswellpark.org
Sachin Kumar, PhDScientist, Dept. of Medical Oncology, Dr BRA-IRCH, All India Institute of Medical SciencesDirección de correo verificada de aiims.edu
Satyendra Chandra TripathiAssociate Professor, All India Institute of Medical Sciences, NagpurDirección de correo verificada de aiimsnagpur.edu.in
Shantanu V. Lale, M.Pharm., Ph.D.Senior Scientist at BlueRock TherapeuticsDirección de correo verificada de bluerocktx.com
Dr. Arun Kumar M.Tech, PhD IIT DelhiCentre for Biomedical Engineering, IIT Delhi and Biomedical Engineering Unit, AIIMS New DelhiDirección de correo verificada de cbme.iitd.ac.in
Govindasamy MugeshIndian Institute of ScienceDirección de correo verificada de iisc.ac.in
Kumaravel SomasundaramIndian Institute of ScienceDirección de correo verificada de mcbl.iisc.ernet.in
Indu KohaarAssistant Professor, USU-WR Surgery, CPDRDirección de correo verificada de cpdr.org
Dr. Rakesh K. Tekade (Associate Prof...NIPER-A, IIT-Jammu, UTSouthwestern Texas (USA); University of Hawaii (USA), UCLan (UK), IMU-MalaysiaDirección de correo verificada de niperahm.ac.in
Subhodeep Sarker, PhD, MBA (苏明)EY-ParthenonDirección de correo verificada de gds.ey.com
Arun Kumar, PhDCoalition for Epidemic Preparedness Innovations (CEPI)Dirección de correo verificada de cepi.net
Dr. Neha singhPt. JNM Medical College Raipur ChhattisgarhDirección de correo verificada de crapo.info
Vinay KulkarniTata Consultancy Services, Pune, IndiaDirección de correo verificada de tcs.com

Seguir

Alok Chandra Bharti

Department of Zoology, University of Delhi, Delhi, INDIA

Dirección de correo verificada de zoology.du.ac.in

Molecular Oncology


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Anticancer potential of curcumin: preclinical and clinical studies BB Aggarwal, A Kumar, AC Bharti Anticancer research 23 (1/A), 363-398, 2003	3764	2003
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of … AC Bharti, N Donato, S Singh, BB Aggarwal Blood, The Journal of the American Society of Hematology 101 (3), 1053-1062, 2003	880	2003
Nuclear factor-kappa B and cancer: its role in prevention and therapy AC Bharti, BB Aggarwal Biochemical pharmacology 64 (5-6), 883-888, 2002	753	2002
Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells AC Bharti, N Donato, BB Aggarwal The journal of immunology 171 (7), 3863-3871, 2003	643	2003
Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis AC Bharti, S Shishodia, JM Reuben, D Weber, R Alexanian, ... Blood 103 (8), 3175-3184, 2004	417	2004
Chronic diseases, inflammation, and spices: how are they linked? AB Kunnumakkara, BL Sailo, K Banik, C Harsha, S Prasad, SC Gupta, ... Journal of translational medicine 16, 1-25, 2018	351	2018
Curcumin (diferuloylmethane) inhibits receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and suppresses osteoclastogenesis AC Bharti, Y Takada, BB Aggarwal The journal of Immunology 172 (10), 5940-5947, 2004	339	2004
Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation K Ashikawa, S Majumdar, S Banerjee, AC Bharti, S Shishodia, ... The Journal of Immunology 169 (11), 6490-6497, 2002	307	2002
Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells S Mahata, AC Bharti, S Shukla, A Tyagi, SA Husain, BC Das Molecular cancer 10, 1-14, 2011	203	2011
The role of TNF and its family members in inflammation and cancer: lessons from gene deletion BB Aggarwal, S Shishodia, K Ashikawa, AC Bharti Current Drug Targets-Inflammation & Allergy 1 (4), 327-341, 2002	194	2002
Infection of human papillomaviruses in cancers of different human organ sites S Shukla, AC Bharti, S Mahata, S Hussain, R Kumar, S Hedau, BC Das Indian Journal of Medical Research 130 (3), 222-233, 2009	189	2009
Differential expression and activation of NF‐κB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection A Mishra, AC Bharti, P Varghese, D Saluja, BC Das International journal of cancer 119 (12), 2840-2850, 2006	157	2006
Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells S Mahata, S Maru, S Shukla, A Pandey, G Mugesh, BC Das, AC Bharti BMC complementary and alternative medicine 12, 1-11, 2012	155	2012
Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-κB mutations or … B Zheng, GV Georgakis, Y Li, A Bharti, D McConkey, BB Aggarwal, ... Clinical Cancer Research 10 (9), 3207-3215, 2004	145	2004
Chemopreventive agents induce suppression of nuclear factor‐κB leading to chemosensitization AC Bharti, BB Aggarwal Annals of the New York Academy of Sciences 973 (1), 392-395, 2002	137	2002
Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection S Shukla, G Shishodia, S Mahata, S Hedau, A Pandey, S Bhambhani, ... Molecular cancer 9, 1-17, 2010	133	2010
Global proficiency study of human papillomavirus genotyping C Eklund, T Zhou, J Dillner Journal of clinical microbiology 48 (11), 4147-4155, 2010	132	2010
Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy RK Tekade, T Dutta, A Tyagi, AC Bharti, BC Das, NK Jain Journal of drug targeting 16 (10), 758-772, 2008	124	2008
Folic acid and trastuzumab functionalized redox responsive polymersomes for intracellular doxorubicin delivery in breast cancer SV Lale, A Kumar, S Prasad, AC Bharti, V Koul Biomacromolecules 16 (6), 1736-1752, 2015	121	2015
Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck AK Chaudhary, M Singh, AC Bharti, K Asotra, S Sundaram, R Mehrotra Journal of biomedical science 17, 1-13, 2010	121	2010

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores